Your browser doesn't support javascript.
loading
Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations.
Sarathy, Jansy; Blanc, Landry; Alvarez-Cabrera, Nadine; O'Brien, Paul; Dias-Freedman, Isabela; Mina, Marizel; Zimmerman, Matthew; Kaya, Firat; Ho Liang, Hsin-Pin; Prideaux, Brendan; Dietzold, Jillian; Salgame, Padmini; Savic, Radojka M; Linderman, Jennifer; Kirschner, Denise; Pienaar, Elsje; Dartois, Véronique.
Afiliación
  • Sarathy J; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
  • Blanc L; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
  • Alvarez-Cabrera N; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
  • O'Brien P; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
  • Dias-Freedman I; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
  • Mina M; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
  • Zimmerman M; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
  • Kaya F; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
  • Ho Liang HP; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
  • Prideaux B; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
  • Dietzold J; Department of Medicine, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
  • Salgame P; Department of Medicine, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
  • Savic RM; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
  • Linderman J; Department of Chemical Engineering, University of Michigan, Ann Arbor, Michigan, USA.
  • Kirschner D; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Pienaar E; Department of Chemical Engineering, University of Michigan, Ann Arbor, Michigan, USA.
  • Dartois V; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Article en En | MEDLINE | ID: mdl-30803965

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fluoroquinolonas / Antituberculosos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Antimicrob Agents Chemother Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fluoroquinolonas / Antituberculosos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Antimicrob Agents Chemother Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos